JPRN-jRCT1080223727已完成Unknown
Post-marketing study
Fuji Yakuhin Co., Ltd., SANWA KAGAKU KENKYUSHO CO.,LTD.0 个研究点目标入组 3,000 人开始时间: 2017年11月22日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- •Hyperuricemic patients with or without gout who have never used topiroxostat.
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
INULEAD Injection PMSRenal function testJPRN-jRCT1080223665Fuji Yakuhin Co., Ltd.1,000
已完成
不适用
A non-interventional, post-marketing survey study of healthcare professionals based on their experience using a high-fiber enteral feeding.ConstipationJPRN-UMIN000048410estle Health Science Company, Nestle Japan Ltd.184
进行中(未招募)
不适用
A study to evaluate the effect of orlistat + resveratrol combination on weight managementObesity and overweightNutritional, Metabolic, EndocrineISRCTN10642495Zydus Lifesciences Ltd264
尚未招募
Unknown
Observational, Postmarketing Study to Evaluate the Safety of AmBisome®CTRI/2023/08/057070Gilead Sciences Inc
尚未招募
4 期
Prospective, multicenter, post-marketing study to evaluate the effectiveness of a monofocal implantable phakic contact lens (IPCL) in myopic and hyperopic patients, with and without astigmatismH52Disorders of refraction and accommodationDRKS00024073Care Group, India40
